TY - JOUR
T1 - High estimated prevalence of asymptomatic dengue viremia in blood donors during a dengue epidemic in southern Taiwan, 2015
AU - Chien, Yu Wen
AU - Shu, Yu Chen
AU - Chuang, Kun Ta
AU - Yeh, Chun Yin
AU - Ko, Wen Chien
AU - Ko, Nai Ying
AU - Perng, Guey Chuen
N1 - Funding Information:
This work was partially supported by the Taiwan Ministry of Science and Technology (former name National Science Council of Taiwan) (Grant MOST 105-2634-B-006-001 [WCK] and NSC 105-2314-B-006-004 [YWC], NSC 102-2320-B-006-049 and MOST 103-2320-B-006-030-MY3 [GCP]) and the National Mosquito-Borne Diseases Control Research Center (Grant MOHW105-TDU-M-212-000006 [NYK] and MOHW104-CDC-C-114-114901 [GCP]).
Publisher Copyright:
© 2017 AABB
PY - 2017/11
Y1 - 2017/11
N2 - BACKGROUND: Southern Taiwan experienced a severe dengue epidemic in 2015. Adult asymptomatic cases would raise concerns on transfusion-transmitted dengue virus (DENV) infection. The aim of this study was to evaluate the magnitude of such a risk in Tainan City during this epidemic. STUDY DESIGN AND METHODS: The daily prevalence of asymptomatic dengue viremia in blood donors in Tainan City and in selected high-incidence districts during the 2015 dengue epidemic was estimated by an established mathematical model. Duration of viremia, duration of viremia before symptom onset, apparent-to-inapparent infection ratio, and reporting-to-underreporting ratio were four main parameters used in the model. RESULTS: The estimated maximal and mean daily prevalence of asymptomatic dengue viremia in blood donors in Tainan during this dengue epidemic was 74.4 (95% confidence interval [CI], 60.8-88.0) and 15.0 (95% CI, 12.3-17.7) per 10,000, respectively. In the district with the highest incidence, the maximal and mean daily prevalence of asymptomatic viremia was 328.8 (95% CI, 271.1-386.2) and 55.3 (95% CI, 43.4-63.3) per 10,000, respectively. Approximately 234 (95% CI, 191-276) blood components containing DENV were produced during the epidemic. CONCLUSION: Although dengue is currently not endemic in Taiwan, physicians need to be aware of the risk of transfusion-transmitted DENV infection. Our results suggest that screening measures to ensure blood safety should be evaluated and implemented during dengue epidemics even in nonendemic areas. Timely estimation of daily asymptomatic viremia prevalence by districts can help to select high-risk areas for such measures and to evaluate cost-effectiveness.
AB - BACKGROUND: Southern Taiwan experienced a severe dengue epidemic in 2015. Adult asymptomatic cases would raise concerns on transfusion-transmitted dengue virus (DENV) infection. The aim of this study was to evaluate the magnitude of such a risk in Tainan City during this epidemic. STUDY DESIGN AND METHODS: The daily prevalence of asymptomatic dengue viremia in blood donors in Tainan City and in selected high-incidence districts during the 2015 dengue epidemic was estimated by an established mathematical model. Duration of viremia, duration of viremia before symptom onset, apparent-to-inapparent infection ratio, and reporting-to-underreporting ratio were four main parameters used in the model. RESULTS: The estimated maximal and mean daily prevalence of asymptomatic dengue viremia in blood donors in Tainan during this dengue epidemic was 74.4 (95% confidence interval [CI], 60.8-88.0) and 15.0 (95% CI, 12.3-17.7) per 10,000, respectively. In the district with the highest incidence, the maximal and mean daily prevalence of asymptomatic viremia was 328.8 (95% CI, 271.1-386.2) and 55.3 (95% CI, 43.4-63.3) per 10,000, respectively. Approximately 234 (95% CI, 191-276) blood components containing DENV were produced during the epidemic. CONCLUSION: Although dengue is currently not endemic in Taiwan, physicians need to be aware of the risk of transfusion-transmitted DENV infection. Our results suggest that screening measures to ensure blood safety should be evaluated and implemented during dengue epidemics even in nonendemic areas. Timely estimation of daily asymptomatic viremia prevalence by districts can help to select high-risk areas for such measures and to evaluate cost-effectiveness.
UR - http://www.scopus.com/inward/record.url?scp=85032958400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032958400&partnerID=8YFLogxK
U2 - 10.1111/trf.14281
DO - 10.1111/trf.14281
M3 - Article
C2 - 28840606
AN - SCOPUS:85032958400
SN - 0041-1132
VL - 57
SP - 2649
EP - 2656
JO - Transfusion
JF - Transfusion
IS - 11
ER -